INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update
The Board of International Biotechnology Trust plc (the "Company") notes the following change to the value of the unquoted portfolio company Cadent Holdings.
Cadent Holdings is now valued on an EBITDA basis, following a sustained period of profitability. This valuation change will be incorporated into the net asset value ("NAV") of the Company from today and reflected in the Company's NAV announcements with effect from tomorrow, 25 August 2010. This increases the NAV by £1.0m, representing 1.7 pence per share.
Enquiries:
Kate Bingham/David Pinniger
Telephone: 020 7412 7070
SV Life Sciences Managers LLP
Investment Manager
Rachael Nelson
Telephone: 020 7410 3132
BNP Paribas Secretarial Services Limited
Company Secretary
24 AUGUST 2010